Skip to content

Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications

Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02663362
Acronym
MRS VALIDATION
Enrollment
250
Registered
2016-01-26
Start date
2012-02-01
Completion date
2027-01-01
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Body Composition, Human Body Function

Keywords

magnetic resonance imaging, magnetic resonance spectroscopy

Brief summary

The purpose of this study is to develop and refine the techniques for using magnetic resonance imaging and magnetic resonance spectroscopy to understand the composition and function of the human body

Interventions

OTHERTo evaluate the reproducibility of acquiring multi-nuclear data on a new 3T Philips Magnet

Outside standard MR instrumentation there will be no interventions.

Sponsors

AdventHealth Translational Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
12 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female * Age 12 - 89 * Healthy (self assessed) * Weight under 350lbs * Able to walk 50 yards without stopping * Able to travel to hospital for study visits * Able to follow a 3-step command * Able to remain in Magnetic Resonance (MR) scanner for up to 2 hours

Exclusion criteria

* Have internal metal medical devices, including cardiac pacemakers, aortic or cerebral aneurysm clips, artificial heart valves, ferromagnetic implants, shrapnel, wire sutures, joint replacements, bone or joint pins/rods/screws, metal fragments in your eye, or non-removable jewelry such as rings. * Are unwilling or unable to complete the imaging procedures for the duration of the MRI scan due to claustrophobia or other reason. * Serious mental illness that might preclude subject's ability to comply with study treatment * Life expectancy of less than 1 year * Are pregnant or plan on becoming pregnant in the next 8 weeks.

Design outcomes

Primary

MeasureTime frame
Whole body fat quantification1 hour

Secondary

MeasureTime frameDescription
Fat Microstructure1 hourA high resolution image of the structure of fat tissue.

Countries

United States

Contacts

CONTACTRecruitment Department
tri@flhosp.org407-303-7100
PRINCIPAL_INVESTIGATORHeather Cornnell, PhD

Translational Research Institute for Metabolism and Diabetes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026